Search - tctmd.com

Displaying 1 - 20 of 117

Sort: Relevancy | Date

Five-Year Follow-up Reassures on Severe Patient-Prosthesis Mismatch in TAVI

News Conference News TVT 2023

Five-Year Follow-up Reassures on Severe Patient-Prosthesis Mismatch in TAVI

June 14, 2023

‘Excellent’ Outcomes With Mitral ViV Procedures, Even in Lower-Risk Patients

News Conference News TVT 2023

‘Excellent’ Outcomes With Mitral ViV Procedures, Even in Lower-Risk Patients

Michael O'Riordan

June 09, 2023

Surgical Outcomes After Failed TEER: More Insights, Red Flags From CUTTING-EDGE

News Conference News TVT 2023

Surgical Outcomes After Failed TEER: More Insights, Red Flags From CUTTING-EDGE

June 08, 2023

Analysis of Procedure Volume and Outcomes of Surgical and Transcatheter Aortic Valve Replacement Following Regulatory Approval of Low-Surgical Risk Patients

Presentation TVT 2023

Analysis of Procedure Volume and Outcomes of Surgical and Transcatheter Aortic Valve Replacement Following Regulatory Approval of Low-Surgical Risk Patients

Presenter: Ghadi Moubarak

June 08, 2023

Association of Low Geriatric Nutritional Risk Index With Transcatheter Aortic Valve Replacement Procedural Futility

Presentation TVT 2023

Association of Low Geriatric Nutritional Risk Index With Transcatheter Aortic Valve Replacement Procedural Futility

Presenter: Rohit Masih

June 08, 2023

Contrapoint: M-TEER in Lower Risk PMR Patients: Putting the “Pro” and “Cons” in Perspective

Presentation TVT 2023

Contrapoint: M-TEER in Lower Risk PMR Patients: Putting the “Pro” and “Cons” in Perspective

Presenter: Michael Mack

June 08, 2023

Point: Technology Evolution of M-TEER Already Allows the Treatment of Complex Anatomies and Lower Risk Patients!

Presentation TVT 2023

Point: Technology Evolution of M-TEER Already Allows the Treatment of Complex Anatomies and Lower Risk Patients!

Presenter: Amar Krishnaswamy

June 08, 2023

Late-Breaking Clinical Science: Three-Year Outcomes From the Evolut Low Risk TAVR Bicuspid Study

Presentation TVT 2023

Late-Breaking Clinical Science: Three-Year Outcomes From the Evolut Low Risk TAVR Bicuspid Study

Presenter: Firas Zahr

June 08, 2023

Less Paravalvular Leak With Newer Acurate neo2 TAVI: Registry

News Conference News TVT 2022

Less Paravalvular Leak With Newer Acurate neo2 TAVI: Registry

Michael O'Riordan

June 13, 2022

Surgical Explant or Redo for TAVI Failures? Some Registry Insights

News Conference News TVT 2022

Surgical Explant or Redo for TAVI Failures? Some Registry Insights

Michael O'Riordan

June 10, 2022

More Support for Single Antiplatelet Therapy After TAVI

News Conference News TVT 2022

More Support for Single Antiplatelet Therapy After TAVI

Michael O'Riordan

June 10, 2022

No Stroke Reduction With Embolic Protection in TAVI, Two Studies Suggest

News Conference News TVT 2022

No Stroke Reduction With Embolic Protection in TAVI, Two Studies Suggest

Michael O'Riordan

June 09, 2022

Key features for a first valve in a low-risk patient

Presentation TVT 2022

Key features for a first valve in a low-risk patient

Presenter: Katherine Harrington

June 09, 2022

New-Generation Watchman FLX Maintains Good Results Through 2 Years

News Conference News TVT 2021

New-Generation Watchman FLX Maintains Good Results Through 2 Years

July 28, 2021

3M TAVR: Minimalist TAVI Pathway Saves Money

News Conference News TVT 2021

3M TAVR: Minimalist TAVI Pathway Saves Money

July 26, 2021

Post-TAVI Pacemaker Rates Down in the US, but ‘Still Quite High’

News Conference News TVT 2021

Post-TAVI Pacemaker Rates Down in the US, but ‘Still Quite High’

July 23, 2021

Pascal Device Works Well for Tricuspid Regurgitation in Commercial Market

News Conference News TVT 2021

Pascal Device Works Well for Tricuspid Regurgitation in Commercial Market

July 22, 2021

Timing of Mitral Surgery After Failed TEER Influences Outcomes

News Conference News TVT 2021

Timing of Mitral Surgery After Failed TEER Influences Outcomes

July 21, 2021

Complete 2-year Follow-Up from Evolut Low Risk Trial

Presentation TVT 2021

Complete 2-year Follow-Up from Evolut Low Risk Trial

Presenter: John Forrest

July 20, 2021

TAVI Outcomes Similar in Low-Risk Bicuspid, Tricuspid Aortic Stenosis at 1 Year

News Conference News TVT 2021

TAVI Outcomes Similar in Low-Risk Bicuspid, Tricuspid Aortic Stenosis at 1 Year

July 20, 2021

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.